These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12109855)

  • 1. MUC1 expression is correlated with nuclear grade and tumor progression in pT1 renal clear cell carcinoma.
    Leroy X; Zerimech F; Zini L; Copin MC; Buisine MP; Gosselin B; Aubert JP; Porchet N
    Am J Clin Pathol; 2002 Jul; 118(1):47-51. PubMed ID: 12109855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of MUC1 mucins inversely correlated with post-surgical survival of renal cell carcinoma patients.
    Fujita K; Denda K; Yamamoto M; Matsumoto T; Fujime M; Irimura T
    Br J Cancer; 1999 Apr; 80(1-2):301-8. PubMed ID: 10390012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Image analysis of proliferating cell nuclear antigen expression and immunohistochemical profiles in renal cell carcinoma associated with acquired cystic kidney disease: comparison with classic renal cell carcinoma.
    Khurana KK; Truong LD; Verani RR
    Mod Pathol; 1998 Apr; 11(4):339-46. PubMed ID: 9578084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas.
    Allory Y; Matsuoka Y; Bazille C; Christensen EI; Ronco P; Debiec H
    Clin Cancer Res; 2005 Feb; 11(3):1190-7. PubMed ID: 15709188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic T1 clear cell renal cell carcinoma: insulin-like growth factor-I receptor expression and disease-specific survival.
    Parker AS; Cheville JC; Blute ML; Igel T; Lohse CM; Cerhan JR
    Cancer; 2004 Jun; 100(12):2577-82. PubMed ID: 15197799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma.
    Ohno Y; Izumi M; Yoshioka K; Ohori M; Yonou H; Tachibana M
    Oncol Rep; 2008 Sep; 20(3):511-6. PubMed ID: 18695899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of caveolin-1 in renal neoplasms.
    Tamaskar I; Choueiri TK; Sercia L; Rini B; Bukowski R; Zhou M
    Cancer; 2007 Aug; 110(4):776-82. PubMed ID: 17594718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
    Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
    Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic significance of fascin expression in clear cell renal cell carcinoma: systematic analysis of primary and metastatic tumor tissues using a tissue microarray technique.
    Zigeuner R; Droschl N; Tauber V; Rehak P; Langner C
    Urology; 2006 Sep; 68(3):518-22. PubMed ID: 16979727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of vitamin D3 receptor in kidney tumors.
    Liu W; Tretiakova M; Kong J; Turkyilmaz M; Li YC; Krausz T
    Hum Pathol; 2006 Oct; 37(10):1268-78. PubMed ID: 16949927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
    Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
    Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of the enzyme that esterifies retinol, lecithin:retinol acyltransferase, in subtypes of human renal cancer and normal kidney.
    Zhan HC; Gudas LJ; Bok D; Rando R; Nanus DM; Tickoo SK
    Clin Cancer Res; 2003 Oct; 9(13):4897-905. PubMed ID: 14581364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.
    Leibovich BC; Cheville JC; Lohse CM; Zincke H; Frank I; Kwon ED; Merchan JR; Blute ML
    J Urol; 2005 Nov; 174(5):1759-63; discussion 1763. PubMed ID: 16217278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
    Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
    Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of platelet-derived growth factor-alpha alpha receptor is associated with tumor progression in clear cell renal cell carcinoma.
    Sulzbacher I; Birner P; Träxler M; Marberger M; Haitel A
    Am J Clin Pathol; 2003 Jul; 120(1):107-12. PubMed ID: 12866380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphologic subtyping of papillary renal cell carcinoma: correlation with prognosis and differential expression of MUC1 between the two subtypes.
    Leroy X; Zini L; Leteurtre E; Zerimech F; Porchet N; Aubert JP; Gosselin B; Copin MC
    Mod Pathol; 2002 Nov; 15(11):1126-30. PubMed ID: 12429790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma.
    Thompson RH; Dong H; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Kwon ED
    Clin Cancer Res; 2007 Mar; 13(6):1757-61. PubMed ID: 17363529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin expression correlates with prognostic variables and survival in clear cell renal cell carcinoma.
    Matusan K; Dordevic G; Stipic D; Mozetic V; Lucin K
    J Surg Oncol; 2006 Sep; 94(4):325-31. PubMed ID: 16917865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.
    Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV
    Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant relationship of matrix metalloproteinase 9 with nuclear grade and prognostic impact of tissue inhibitor of metalloproteinase 2 for incidental clear cell renal cell carcinoma.
    Kawata N; Nagane Y; Hirakata H; Ichinose T; Okada Y; Yamaguchi K; Takahashi S
    Urology; 2007 Jun; 69(6):1049-53. PubMed ID: 17572184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.